Merit Medical Launches the Prelude Roadster™ Guide Sheath
September 12 2022 - 9:25AM
Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global
manufacturer and marketer of healthcare technology, today announced
U.S. commercial release of the Prelude Roadster™ Guide Sheath. The
Prelude Roadster is the newest addition to the Merit
Vascular-Peripheral Access portfolio, which includes introducers
and other products, including access kits, vessel dilators, and
accessories.
The device is designed for deliverability, visibility, and
resilience in tortuous peripheral vasculature anatomies. Indicated
for use in a variety of procedures, the device will also help
deliver devices used to diagnose and treat the large patient
population who suffer from peripheral artery disease (PAD).
PAD is the narrowing or blockage of the vessels, mainly in the
legs and lower extremities, that prevents blood flow to these
areas. Approximately 6.5 million people aged 40 and older have PAD
in the United States.1 A serious condition, PAD is associated with
a twofold increased prevalence of heart failure as well as the risk
of limb amputation.2 To diagnose and treat PAD, procedures are
performed to detect and open blocked vessels.
“Patients with peripheral vascular disease often have complex
vessel anatomies that make treatment challenging,” said Sandeep
Nathan, MD, MSC, interventional cardiologist, director of the
Coronary Care Unit at the University of Chicago Medicine, and a
consultant of Merit Medical. “The Roadster sheath is designed to
help physicians deliver the diagnostic and therapeutic devices
needed to achieve successful outcomes.”
Learn more about the Prelude Roadster Guide Sheath.
“The Prelude Roadster is an example of Merit’s commitment to
understanding, innovating, and delivering products to meet the
needs of physicians. After decades of offering vascular access
products, we are always searching for ways to help physicians
diagnose and treat successfully, improving the lives of patients
worldwide,” said Fred P. Lampropoulos, Merit Medical’s Chairman and
CEO. “Peripheral procedures improve and save lives and the Prelude
Roadster can help make these procedures available to more
patients.”
ABOUT MERIT MEDICAL Founded in 1987, Merit Medical Systems, Inc.
is engaged in the development, manufacture, and distribution of
proprietary disposable medical devices used in interventional,
diagnostic, and therapeutic procedures, particularly in cardiology,
radiology, oncology, critical care, and endoscopy. Merit serves
client hospitals worldwide with a domestic and international sales
force and clinical support team totaling in excess of 600
individuals. Merit employs approximately 6,500 people
worldwide.
TRADEMARKS Unless noted otherwise, trademarks and registered
trademarks used in this release are the property of Merit Medical
Systems, Inc. and its subsidiaries in the United States and other
jurisdictions.
CONTACTSPR/Media InquiriesSarah ComstockMerit
Medical+1-801-432-2864 | sarah.comstock@merit.com
INVESTOR INQUIRIESMike Piccinino, CFA, IRCWestwicke -
ICR+1-443-213-0509 | mike.piccinino@westwicke.com
1. Centers for Disease Control and Prevention. 2021. “Peripheral
Artery Disease (PAD).” https://www.cdc.gov/heartdisease/PAD.htm
2. Shu and Santulli. 2018. “Update on Peripheral Artery Disease:
Epidemiology and Evidence-Based Facts.” Atherosclerosis 275: 379 ̶
381. PMID: 29843915.
Merit Medical Systems (NASDAQ:MMSI)
Historical Stock Chart
From Jun 2024 to Jul 2024
Merit Medical Systems (NASDAQ:MMSI)
Historical Stock Chart
From Jul 2023 to Jul 2024